Kytopen
  • TECHNOLOGY ACCESS PROGRAM
  • NEWS
  • PEOPLE
    • LEADERSHIP
    • PARTNERS
    • JOIN US
  • LEARN
    • OUR PRODUCTS
    • RESOURCES
    • BROCHURES
  • CONTACT
    • REQUEST QUOTE
    • SUPPORT
  • TECHNOLOGY ACCESS PROGRAM
  • NEWS
  • PEOPLE
    • LEADERSHIP
    • PARTNERS
    • JOIN US
  • LEARN
    • OUR PRODUCTS
    • RESOURCES
    • BROCHURES
  • CONTACT
    • REQUEST QUOTE
    • SUPPORT
Untitled design (69)

 

Explore our growing ecosystem of scientific insights, real-world applications, and expert-led discussions. 

Untitled design (69)-1

Content Spotlight

Featured Webinar with BioInsights

Kytopen joined BioInsights to share how the Flowfect® platform enables rapid, efficient, and scalable non-viral delivery. In this expert-led session, our scientists walk through key workflow advantages, real-world data, and how to accelerate therapeutic development with streamlined manufacturing.

Watch the Webinar Now

Resource Library

Screen Shot 2025-08-04 at 3.25.43 PM
June 12, 2025

Non-viral GMP manufacturing for engineered cells at clinical and commercial scale

Screen Shot 2025-08-05 at 10.59.37 AM
September 17, 2024

Advancements in Electroporation: Enhancing Gene-Modified Cell Therapy for Scalability and Efficacy

ISCT Logo
May 6-10, 2025

View 4 Posters Presented at ISCT 2025

Screen Shot 2025-08-08 at 1.05.34 PM
September 17 - 20, 2024
A Non-viral Pathway to GMP Manufacture Engineered Cell Therapies – Maximizing Yields of Highest Quality Cells
Screen Shot 2025-08-08 at 12.59.08 PM
October 24 - 27, 2023

Optimization and characterization of donor-to-donor variability of primary natural killer cells transfected with RNP

Screen Shot 2025-08-08 at 12.59.08 PM
October 11-14, 2022

Delivery of mRNA and CRISPR-Cas9 RNP to primary Natural Killer cells and T cells using Flowfect®, a new transfection technology

Screen Shot 2025-08-08 at 1.04.55 PM
October 26, 2021

Electro-mechanical transfection for non-viral primary immune cell engineering

Screen Shot 2025-08-08 at 1.04.01 PM
May 16-19, 2022

CRISPR-Cas9 RNP Editing of Primary T Cells Using the Flowfect® Transfection Technology Platform

Screen Shot 2025-08-08 at 1.00.44 PM
May 4-7, 2022

CRISPR-Cas9 RNP editing of primary T cells using the Flowfect® transfection technology platform

Screen Shot 2025-08-08 at 1.01.45 PM
June 23-27, 2020

Flowfect® Transfection of iPSCs Maintains Cell Pluripotency

Screen Shot 2025-08-08 at 1.04.01 PM
May 12-15, 2020

Flowfect®: A scalable non-viral delivery process for T cell engineering

Screen Shot 2025-08-08 at 2.18.46 PM
February 19, 2016

Microfluidic Screening of Electric Fields for Electroporation

Can't find what you're looking for? Contact Us
Kytopen

KYTOPEN
750 Main Street
Cambridge, MA 02139

 

363 Centennial Parkway
Louisville, CO 80027

 

hello@kytopen.com

 

Codes/Standards

Copyright © 2024 Kytopen Corp | All Rights Reserved.